To our knowledge, this would be the first Canadian real-world study to attempt to longitudinally measure the impact of hypoglycemia on utility and productivity loss, including absenteeism, presenteeism, and unpaid work, in insulin-treated patients with T2DM. The gene discussed is INS; the disease is Hypoglycemia.